Mounjaro, chemically known as tirzepatide, is a medication that was approved by the FDA to treat type 2 diabetes. It is expected to be approved by the FDA as a drug for weight loss as well. Depending on the dosage, it has been shown to help people lose 15% to 26% of their body weight over 72 weeks. This drug provides a dual benefit of blood sugar control and weight management.
To read the full article by Paul Wynn click here